image of Defining Optimal Immunotherapies for Type 1 Diabetes (Novartis Foundation Symposium 292)

Defining Optimal Immunotherapies for Type 1 Diabetes (Novartis Foundation Symposium 292)

Publication Year:
2008
Edition:
1st
Author:
Novartis Foundation
Publisher:
Wiley
ISBN:
978-0-47-072325-8
Print/PDF
Request Information
  • Description
  • Details
Description
This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
The book brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials. It integrates information from human and animal studies and considers T1D within the broader context of autoimmune disease. The
format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure
Details
Platform:
OvidSP
Publisher:
Wiley
Product Type:
Book
Author:
Novartis Foundation
ISBN:
978-0-47-072325-8
Specialty:
  • Endocrinology & Metabolism
  • Internal Medicine
Language:
English
Edition:
1st
Pages:
222
Publication Year:
2008

Request Information